These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 211064)
1. Effect of N-(3,5-dichlorophenyl)succinimide on the histological pattern and incidence of kidney tumors induced by streptozotocin rats. Shinohara Y; Miyata Y; Murasaki G; Nakanishi K; Yoshimura T; Ito N Gan; 1977 Aug; 68(4):397-404. PubMed ID: 211064 [TBL] [Abstract][Full Text] [Related]
2. Combination effect of citrinin and other chemicals on rat kidney tumorigenesis. Shinohara Y; Arai M; Hirao K; Sugihara S; Nakanishi K Gan; 1976 Apr; 67(2):147-55. PubMed ID: 964548 [TBL] [Abstract][Full Text] [Related]
3. Tumorigenic action of streptozotocin on the pancreas and kidney in male Wistar rats. Kazumi T; Yoshino G; Fujii S; Baba S Cancer Res; 1978 Jul; 38(7):2144-7. PubMed ID: 207424 [TBL] [Abstract][Full Text] [Related]
4. Effect of N-(3,5-dichlorophenyl)succinimide on the histological pattern and incidence of kidney tumors in rats induced by dimethylnitrosoamine. Ito N; Sugihara S; Makiura S; Arai M; Hirao K Gan; 1974 Apr; 65(2):131-8. PubMed ID: 4366073 [No Abstract] [Full Text] [Related]
5. Electron microscopic observations on the morphogenesis of renal cell carcinoma induced in rat kidney by dimethylnitrosamine and N-(3,5-dichlorophenyl)succinimide. Sugihara R; Sugihara S Cancer Res; 1976 Feb; 36(2 Pt 1):533-50. PubMed ID: 1260752 [TBL] [Abstract][Full Text] [Related]
6. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors. Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889 [TBL] [Abstract][Full Text] [Related]
7. Glucagon secretion in rats with islet cell tumors induced by streptozotocin. Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S Horm Metab Res; 1980 Jan; 12(1):40-1. PubMed ID: 6244219 [No Abstract] [Full Text] [Related]
8. Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes. Rakieten N; Gordon BS; Beaty A; Cooney DA; Schein PS; Dixon RL Proc Soc Exp Biol Med; 1976 Feb; 151(2):356-61. PubMed ID: 175379 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the tumorigenic action of streptozotocin and on the physiologic responses to glucose loading in tumor-bearing rats (author's transl)]. Yoshino G; Kazumi T; Baba S Nihon Naibunpi Gakkai Zasshi; 1978 Sep; 54(9):1070-8. PubMed ID: 214359 [No Abstract] [Full Text] [Related]
10. Liver, kidney and islet cell tumors in spontaneously hypertensive and normotensive rats treated neonatally with streptozotocin. Iwase M; Nunoi K; Sadoshima S; Kikuchi M; Fujishima M Tohoku J Exp Med; 1989 Oct; 159(2):83-90. PubMed ID: 2532796 [TBL] [Abstract][Full Text] [Related]
11. Neoplastic lesions in streptozotocin-treated rats. Okawa H; Doi K Jikken Dobutsu; 1983 Apr; 32(2):77-84. PubMed ID: 6225653 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin. Pour PM; Kazakoff K; Carlson K Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330 [TBL] [Abstract][Full Text] [Related]
13. Biochemical studies on rats with insulin-secreting islet cell tumors induced by streptozotocin: with special reference to physiological response to oral glucose load in the course of and after tumor induction. Kazumi T; Yoshino G; Yoshida Y; Doi K; Yoshida M; Kaneko S; Baba S Endocrinology; 1978 Nov; 103(5):1541-5. PubMed ID: 218781 [TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873 [TBL] [Abstract][Full Text] [Related]
15. Effect of calcium antagonist on glucose-induced insulin and glucagon secretion in rats with insulin-secreting tumors induced by streptozotocin and nicotinamide. Baba S; Yoshino G; Kazumi T; Fujii S; Yoshida Y; Taniguchi H; Morita S Kobe J Med Sci; 1979 Jun; 25(2):93-104. PubMed ID: 224248 [No Abstract] [Full Text] [Related]
16. Induction of malignant kidney tumors in rats with streptozotocin. Mauer SM; Lee CS; Najarian JS; Brown DM Cancer Res; 1974 Jan; 34(1):158-60. PubMed ID: 4272120 [No Abstract] [Full Text] [Related]
17. [Biochemical studies on rats in the course of the induction of insulin-secreting islet cell tumors by streptozotocin (author's transl)]. Kazumi T Nihon Naibunpi Gakkai Zasshi; 1978 Nov; 54(11):1290-305. PubMed ID: 214356 [No Abstract] [Full Text] [Related]
18. Experimental hypoglycemizing tumor of B-cells of Langerhans islets produced by the combined action of streptozotocin annd nicotinamide in the rat. Korec R Neoplasma; 1978; 25(2):157-62. PubMed ID: 205809 [TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-releasing hormone and insulin in chemically induced pancreatic islet cell tumors in rats. Kazumi T; Hirose Y; Ishihara K; Makimura H; Yoshino G; Utsumi M; Baba S Horm Metab Res; 1986 Sep; 18(9):584-6. PubMed ID: 3023223 [TBL] [Abstract][Full Text] [Related]
20. Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide. Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S Endocrinol Jpn; 1979 Dec; 26(6):655-60. PubMed ID: 232037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]